| 1 | Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions | 13.9 | 19 | Citations (PDF) |
| 2 | Ischemia targeted coronary revascularization improves 5-year survival following carotid endarterectomy | 2.0 | 1 | Citations (PDF) |
| 3 | Percutaneous Coronary Intervention for Left Main Disease in High Bleeding Risk: Outcomes from a Subanalysis of the Delta 2 Registry | 1.5 | 0 | Citations (PDF) |
| 4 | Challenges in the prevention, treatment and management of cardiovascular disease among older adults | 6.8 | 19 | Citations (PDF) |
| 5 | Effect of Body Mass Index on Effectiveness of CT versus Invasive Coronary Angiography in Stable Chest Pain: The DISCHARGE Trial | 7.2 | 1 | Citations (PDF) |
| 6 | Long-term prognostic implications of CT angiography-derived fractional flow reserve: Results from the DISCOVER-FLOW study | 1.7 | 20 | Citations (PDF) |
| 7 | Coronary Artery Calcium Score Predicts Major Adverse Cardiovascular Events in Stable Chest Pain | 7.2 | 33 | Citations (PDF) |
| 8 | Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence? | 13.9 | 36 | Citations (PDF) |
| 9 | Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The PiCSO-AMI-I Trial | 3.5 | 19 | Citations (PDF) |
| 10 | Addressing the Need to Improve Long Term Survival Following Lower Extremity Revascularisation in a Randomised Controlled Trial | 1.4 | 2 | Citations (PDF) |
| 11 | Bioresorbable Scaffold Use in Coronary Chronic Total Occlusions: A Long-Term, Single-Center Follow-Up Study | 1.6 | 1 | Citations (PDF) |
| 12 | Quality of Life in Patients with Atrial Fibrillation Undergoing Pulmonary Vein Isolation: Short-Term Follow-Up Study | 1.6 | 2 | Citations (PDF) |
| 13 | Association Between Self-Rated Health and Cardiovascular Risk Factors in Latvia | 0.1 | 0 | Citations (PDF) |
| 14 | Impact of technique on bifurcation stent outcomes in the European Bifurcation Club Left Main Coronary Trial | 1.3 | 3 | Citations (PDF) |
| 15 | Bifurcation left main stenting with or without intracoronary imaging: Outcomes from the EBC MAIN trial | 1.3 | 7 | Citations (PDF) |
| 16 | Five-Year Clinical Outcomes of the COBRA Polyzene F NanoCoated Coronary Stent System | 0.5 | 6 | Citations (PDF) |
| 17 | What Is Hidden Behind Yellow Pixels: from Pathology to Intravascular Imaging of Atherosclerotic Plaque | 3.6 | 1 | Citations (PDF) |
| 18 | Stent-Save a Life international survey on the practice of primary percutaneous coronary intervention during the COVID-19 pandemic | 0.6 | 6 | Citations (PDF) |
| 19 | Comparative Analysis of the Most Important Cardiovascular Risk Factors Based on Cross-Sectional Studies in the Population of Latvia | 1.6 | 3 | Citations (PDF) |
| 20 | Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES∗ | 1.8 | 16 | Citations (PDF) |
| 21 | Coronary revascularization of patients with silent coronary ischemia may reduce the risk of myocardial infarction and cardiovascular death after carotid endarterectomy | 2.0 | 16 | Citations (PDF) |
| 22 | Coronary Artery Disease in Women: Lessons Learned from Single-Center SPECT Registry and Future Directions for INOCA Patients | 1.6 | 2 | Citations (PDF) |
| 23 | Coronary revascularization of patients with silent coronary ischemia may reduce the risk of myocardial infarction and cardiovascular death after carotid endarterectomyPresented at the 2022 Vascular Annual Meeting of the Society for Vascular Surgery, Boston, Mass, June 15-18, 2022. | 1.4 | 0 | Citations (PDF) |
| 24 | Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent | 1.3 | 6 | Citations (PDF) |
| 25 | Diagnosis and management of silent coronary ischemia in patients undergoing carotid endarterectomy | 2.0 | 11 | Citations (PDF) |
| 26 | Comparison of outcome between blood culture positive and negative infective endocarditis patients undergoing cardiac surgery | 0.9 | 14 | Citations (PDF) |
| 27 | Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology | 7.4 | 76 | Citations (PDF) |
| 28 | Two-year outcomes from the MitrAl ValvE RepaIr Clinical (MAVERIC) trial: a novel percutaneous treatment of functional mitral regurgitation | 4.8 | 13 | Citations (PDF) |
| 29 | Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial | 13.9 | 249 | Citations (PDF) |
| 30 | Pacemaker‐Based Cardiac Neuromodulation Therapy in Patients With Hypertension: A Pilot Study | 3.2 | 29 | Citations (PDF) |
| 31 | The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial | 1.9 | 12 | Citations (PDF) |
| 32 | A case report of pulmonary vein isolation performed in a patient with polysplenia and interrupted inferior vena cava. | 0.3 | 2 | Citations (PDF) |
| 33 | Five-Year Results of the Bioflow-III Registry: Real-World Experience with a Biodegradable Polymer Sirolimus-Eluting Stent | 0.5 | 14 | Citations (PDF) |
| 34 | Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial | 49.6 | 374 | Citations (PDF) |
| 35 | European Society of Cardiology: Cardiovascular Disease Statistics 2019 | 7.4 | 866 | Citations (PDF) |
| 36 | Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry | 0.5 | 3 | Citations (PDF) |
| 37 | Pre-operative Diagnosis of Silent Coronary Ischaemia May Reduce Post-operative Death and Myocardial Infarction and Improve Survival of Patients Undergoing Lower Extremity Surgical Revascularisation | 1.4 | 19 | Citations (PDF) |
| 38 | Health-related qualify of life, angina type and coronary artery disease in patients with stable chest pain | 2.0 | 24 | Citations (PDF) |
| 39 | Clinical pre-test probability for obstructive coronary artery disease: insights from the European DISCHARGE pilot study | 3.2 | 13 | Citations (PDF) |
| 40 | Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve–Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial | 9.6 | 31 | Citations (PDF) |
| 41 | Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial | 13.2 | 267 | Citations (PDF) |
| 42 | Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve–Guided Revascularization Strategy | 2.0 | 31 | Citations (PDF) |
| 43 | Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study | 49.6 | 382 | Citations (PDF) |
| 44 | Lead-Related Infective Endocarditis in Latvia: A Single Centre Experience | 1.6 | 3 | Citations (PDF) |
| 45 | Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment. | 6.5 | 37 | Citations (PDF) |
| 46 | Derivation and Validation of a Chronic Total Coronary Occlusion Intervention Procedural Success Score From the 20,000-Patient EuroCTO Registry | 2.0 | 139 | Citations (PDF) |
| 47 | Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial | 7.4 | 56 | Citations (PDF) |
| 48 | Prognostic Value and Risk Continuum of Noninvasive Fractional Flow Reserve Derived from Coronary CT Angiography | 7.2 | 131 | Citations (PDF) |
| 49 | Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. | 1.6 | 738 | Citations (PDF) |
| 50 | New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry | 1.7 | 5 | Citations (PDF) |
| 51 | Mid-term outcomes after percutaneous interventions in coronary bifurcations | 1.7 | 35 | Citations (PDF) |
| 52 | Treatment of Knee Osteoarthritis with Bone Marrow–Derived Mononuclear Cell Injection: 12-Month Follow-up | 2.3 | 31 | Citations (PDF) |
| 53 | A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions | 7.4 | 487 | Citations (PDF) |
| 54 | New-Generation Drug-Eluting Stents for Left Main In-Stent Restenosis | 2.0 | 5 | Citations (PDF) |
| 55 | 1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration. | 2.0 | 24 | Citations (PDF) |
| 56 | Latvian registry of familial hypercholesterolemia: The first report of three-year results | 1.9 | 13 | Citations (PDF) |
| 57 | Chronic Total Coronary Artery Occlusion Recanalisation with Percutaneous Coronary Intervention — Single Centre 10-Year Experience | 0.1 | 1 | Citations (PDF) |
| 58 | Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey | 1.7 | 26 | Citations (PDF) |
| 59 | Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes | 2.0 | 127 | Citations (PDF) |
| 60 | Two-year clinical outcomes after implantation of an everolimus-eluting bioresorbable scaffold (Absorb) in stable angina and acute coronary syndrome patients. Single-centre real-life registry data | 0.5 | 2 | Citations (PDF) |
| 61 | Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study | 4.0 | 22 | Citations (PDF) |
| 62 | Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial. | 2.3 | 19 | Citations (PDF) |
| 63 | New Modalities in Knee Osteoarthritis Treatment Using Autologous Bone Marrow-Derived Mononuclear Cells | 0.1 | 0 | Citations (PDF) |
| 64 | 9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System. | 2.0 | 41 | Citations (PDF) |
| 65 | Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome | 1.3 | 11 | Citations (PDF) |
| 66 | Design and rationale for the nfluenza vaccination fter yocardial nfarction (IAMI) trial. A registry-based randomized clinical trial | 1.9 | 43 | Citations (PDF) |
| 67 | New insight to estimate under-expansion after stent implantation on bifurcation lesions using optical coherence tomography | 1.0 | 12 | Citations (PDF) |
| 68 | The comparison of knee osteoarthritis treatment with single-dose bone marrow-derived mononuclear cells vs. hyaluronic acid injections | 1.6 | 31 | Citations (PDF) |
| 69 | Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI | 25.2 | 864 | Citations (PDF) |
| 70 | The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis): Angiographic Results and 1-Year Clinical Outcomes. | 2.0 | 71 | Citations (PDF) |
| 71 | Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS) | 0.5 | 16 | Citations (PDF) |
| 72 | One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent | 1.7 | 18 | Citations (PDF) |
| 73 | Evaluating the quality of implantation of percutaneous ventricular restoration device (Parachute®) by cardiac computed tomography | 1.3 | 2 | Citations (PDF) |
| 74 | Pacemaker‐Mediated Programmable Hypertension Control Therapy | 3.2 | 35 | Citations (PDF) |
| 75 | A randomized, multi-center, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis (RADAR) – one-year results of a pre-maturely terminated study | 1.2 | 35 | Citations (PDF) |
| 76 | P6234Lipid goals are poorly attained in majority of patients with familial hypercholesterolemia in Latvia at the time of inclusion in the national registry | 7.4 | 1 | Citations (PDF) |
| 77 | The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease. | 2.0 | 40 | Citations (PDF) |
| 78 | How should I treat this mini-crush stenting complication? | 2.3 | 6 | Citations (PDF) |
| 79 | European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions | 4.8 | 686 | Citations (PDF) |
| 80 | Carotid artery stenting outcomes in high-risk patients receiving best medical therapy: results from a single high-volume interventional cardiology practice | 0.2 | 0 | Citations (PDF) |
| 81 | Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study | 7.4 | 111 | Citations (PDF) |
| 82 | Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry. | 2.0 | 25 | Citations (PDF) |
| 83 | Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial | 49.6 | 630 | Citations (PDF) |
| 84 | Cardiac computed tomography assessment of the near term impact of percutaneous ventricular restoration therapy (parachute®) on mitral valve geometry | 1.3 | 2 | Citations (PDF) |
| 85 | 1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry. | 2.0 | 46 | Citations (PDF) |
| 86 | Pilot study of safety and efficacy of polyprenols in combination with coenzyme Q10 in patients with statin-induced myopathy | 1.6 | 10 | Citations (PDF) |
| 87 | EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. | 1.6 | 762 | Citations (PDF) |
| 88 | Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial | 3.2 | 40 | Citations (PDF) |
| 89 | Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: Analysis of the CLARIFY registry | 1.6 | 6 | Citations (PDF) |
| 90 | Randomized evaluation of a novel, fixed-dose combination of perindopril 3.5 mg/amlodipine 2.5 mg as a first-step treatment in hypertension | 1.5 | 18 | Citations (PDF) |
| 91 | Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL–C levels in a latvian population | 1.8 | 18 | Citations (PDF) |
| 92 | Prevalence estimation of celiac disease in the general adult population of Latvia using serology and HLA genotyping | 3.1 | 8 | Citations (PDF) |
| 93 | Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology | 8.4 | 108 | Citations (PDF) |
| 94 | Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure | 13.9 | 578 | Citations (PDF) |
| 95 | A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure. | 7.4 | 80 | Citations (PDF) |
| 96 | Atherosclerotic Plaque Characteristics by CT Angiography Identify Coronary Lesions That Cause Ischemia: A Direct Comparison to Fractional Flow Reserve | 4.2 | 261 | Citations (PDF) |
| 97 | In-vivo iMap IVUS comparison of in-stent neointima and native coronary atherosclerosis | 0.5 | 0 | Citations (PDF) |
| 98 | Primary endpoint results of the OMEGA Study: One-year clinical outcomes after implantation of a novel platinum chromium bare metal stent | 0.5 | 15 | Citations (PDF) |
| 99 | Treatment of Heart Failure With Associated Functional Mitral Regurgitation Using the ARTO System: Initial Results of the First-in-Human MAVERIC Trial (Mitral Valve Repair Clinical Trial) | 2.0 | 51 | Citations (PDF) |
| 100 | Percutaneous ventricular restoration (PVR) therapy using the Parachute device in 100 subjects with ischaemic dilated heart failure: one-year primary endpoint results of PARACHUTE III, a European trial. | 2.3 | 32 | Citations (PDF) |
| 101 | Insufficient control of heart rate in stable coronary artery disease patients in Latvia | 1.6 | 1 | Citations (PDF) |
| 102 | Plaque and blood vulnerability in ST segment elevation myocardial infarction patients | 1.2 | 0 | Citations (PDF) |
| 103 | Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. | 7.4 | 263 | Citations (PDF) |
| 104 | Long-Term Outcomes of Percutaneous Coronary Interventions or Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease in Octogenarians (from a Drug-Eluting stent for LefT main Artery Registry Substudy) | 1.5 | 19 | Citations (PDF) |
| 105 | Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. | 2.0 | 40 | Citations (PDF) |
| 106 | Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of the Left Main Coronary Artery (from the Women–Drug-Eluting stent for LefT main coronary Artery disease Registry) | 1.5 | 11 | Citations (PDF) |
| 107 | A novel noninvasive technology for treatment planning using virtual coronary stenting and computed tomography-derived computed fractional flow reserve. | 2.0 | 136 | Citations (PDF) |
| 108 | Diagnostic Performance of Noninvasive Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography in Suspected Coronary Artery Disease: The NXT Trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps) | 6.5 | 1,458 | Citations (PDF) |
| 109 | Prevalence of dyslipidemia in statin-treated patients in the Baltic states (Estonia, Latvia, and Lithuania): Results of the Dyslipidemia International Study (DYSIS) | 1.6 | 9 | Citations (PDF) |
| 110 | Role of genetic factors on the effect of additional loading doses and two maintenance doses used to overcome clopidogrel hyporesponsiveness | 1.6 | 3 | Citations (PDF) |
| 111 | Intravascular Ultrasound-based Imaging Modalities for Tissue Characterisation | 1.5 | 15 | Citations (PDF) |
| 112 | Intrapulmonary Administration of Autologous Bone Marrow Derived Mononuclear Cells in Congenital Heart Disease Complicated by Pulmonary Arterial Hypertension: A Case Report | 0.2 | 1 | Citations (PDF) |
| 113 | Long-Term Results After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions | 6.5 | 150 | Citations (PDF) |
| 114 | Long-Term Clinical Outcomes After Percutaneous Coronary Intervention for Ostial/Mid-Shaft Lesions Versus Distal Bifurcation Lesions in Unprotected Left Main Coronary Artery | 2.0 | 73 | Citations (PDF) |
| 115 | Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results. | 2.0 | 50 | Citations (PDF) |
| 116 | Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease. | 2.0 | 48 | Citations (PDF) |
| 117 | Intravascular ultrasound assessed incomplete stent apposition and stent fracture in stent thrombosis after bare metal versus drug-eluting stent treatment the Nordic Intravascular Ultrasound Study (NIVUS) | 1.7 | 26 | Citations (PDF) |
| 118 | iMap intravascular ultrasound evaluation of culprit and non-culprit lesions in patients with ST-elevation myocardial infarction | 0.5 | 12 | Citations (PDF) |
| 119 | A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: The AVIO trial | 1.9 | 236 | Citations (PDF) |
| 120 | Noninvasive Fractional Flow Reserve Derived From Computed Tomography Angiography for Coronary Lesions of Intermediate Stenosis Severity: Results From the DeFACTO Study | 2.7 | 238 | Citations (PDF) |
| 121 | Follow-up of the patients after stem cell transplantation for pediatric dilated cardiomyopathy | 0.9 | 29 | Citations (PDF) |
| 122 | Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry | 4.8 | 558 | Citations (PDF) |
| 123 | Projected Costs and Consequences of Computed Tomography-Determined Fractional Flow Reserve | 1.5 | 72 | Citations (PDF) |
| 124 | Tissue characteristics in non-culprit lesions during the acute coronary event and at ten months follow-up | 7.4 | 0 | Citations (PDF) |
| 125 | Neo-Revascularization as the Potential Treatment for Patient Suffering from Pulmonary Arterial Hypertension (Myth or Reality) | 0.8 | 0 | Citations (PDF) |
| 126 | Management of Idiopathic Dilated Cardiomyopathy with Intramyocardial Stem Cell Transplantation in Children: A Retrospective Study of 7 Patients | 0.0 | 1 | Citations (PDF) |
| 127 | Safeguards and Pitfalls in Technique Used for Stem Cell Delivery in Children Suffering from Idiopathic Dilated Cardiomyopathy | 0.0 | 0 | Citations (PDF) |
| 128 | Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia | 1.1 | 37 | Citations (PDF) |
| 129 | Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures. | 7.4 | 333 | Citations (PDF) |
| 130 | Diagnostic Accuracy of Fractional Flow Reserve From Anatomic CT Angiography | 20.0 | 1,067 | Citations (PDF) |
| 131 | Effect of image quality on diagnostic accuracy of noninvasive fractional flow reserve: Results from the prospective multicenter international DISCOVER-FLOW study | 1.7 | 84 | Citations (PDF) |
| 132 | Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. | 2.0 | 111 | Citations (PDF) |
| 133 | Noninvasive diagnosis of ischemia-causing coronary stenosis using CT angiography: diagnostic value of transluminal attenuation gradient and fractional flow reserve computed from coronary CT angiography compared to invasively measured fractional flow reserve. | 4.2 | 120 | Citations (PDF) |
| 134 | Usefulness of Noninvasive Fractional Flow Reserve Computed from Coronary Computed Tomographic Angiograms for Intermediate Stenoses Confirmed by Quantitative Coronary Angiography | 1.5 | 77 | Citations (PDF) |
| 135 | A Population-Based Cross-Sectional Study of Cardiovascular Risk Factor in Latvia | 1.6 | 8 | Citations (PDF) |
| 136 | Three-Dimensional Fourier-Domain Optical Coherence Tomography Imaging: Advantages and Future Development | 0.3 | 5 | Citations (PDF) |
| 137 | Diagnosis of Ischemia-Causing Coronary Stenoses by Noninvasive Fractional Flow Reserve Computed From Coronary Computed Tomographic Angiograms | 6.5 | 1,305 | Citations (PDF) |
| 138 | Simple or Complex Stenting for Bifurcation Coronary Lesions: A Patient-Level Pooled-Analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study | 3.5 | 143 | Citations (PDF) |
| 139 | A common promoter variant of the gene encoding cyclooxygenase-1 (PTGS1) is related to decreased incidence of myocardial infarction in patients with coronary artery disease | 1.6 | 4 | Citations (PDF) |
| 140 | Are Paclitaxel-Eluting Stents Better in Unprotected Left Main Coronary Artery Disease? Three-Year Clinical and Intravascular Imaging Results From a Randomized Study | 1.6 | 1 | Citations (PDF) |
| 141 | Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty). | 2.0 | 95 | Citations (PDF) |
| 142 | Extended follow-up safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: Two-year follow-up from the E-Five Registry | 1.3 | 11 | Citations (PDF) |
| 143 | Randomized Comparison of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation in Patients With Coronary Bifurcation Lesions Treated With Main Vessel Stenting: The Nordic-Baltic Bifurcation Study III | 13.9 | 255 | Citations (PDF) |
| 144 | A Nonsynonymous Variant I248L of the Adenosine A3 Receptor Is Associated with Coronary Heart Disease in a Latvian Population | 1.8 | 8 | Citations (PDF) |
| 145 | Single nucleotide polymorphisms of the purinergic 1 receptor are not associated with myocardial infarction in a Latvian population | 2.0 | 13 | Citations (PDF) |
| 146 | Lessons for the treatment of bifurcation lesions: from nowadays to the future | 0.0 | 1 | Citations (PDF) |
| 147 | Novel Baroreflex Activation Therapy in Resistant Hypertension | 6.5 | 326 | Citations (PDF) |
| 148 | Randomized Comparison of Coronary Bifurcation Stenting With the Crush Versus the Culotte Technique Using Sirolimus Eluting Stents: The Nordic Stent Technique Study | 3.5 | 142 | Citations (PDF) |
| 149 | Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis | 0.1 | 257 | Citations (PDF) |
| 150 | Safety in simple versus complex stenting of coronary artery bifurcation lesions. The nordic bifurcation study 14-month follow-up results. | 2.3 | 50 | Citations (PDF) |
| 151 | A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis. | 6.5 | 90 | Citations (PDF) |
| 152 | Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction | 25.2 | 481 | Citations (PDF) |
| 153 | Intravascular Ultrasound Data and Results of Serum Biochemical Indices at the Time of Stenting and after Six Months in Patients with Coronary Artery Disease | 0.5 | 1 | Citations (PDF) |
| 154 | Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions: The Nordic Bifurcation Study | 13.9 | 614 | Citations (PDF) |
| 155 | Inflammation, Homocysteine, Pyridoxal-5-phosphate and Lipids in Patients with Coronary Artery Disease before and Six Months after Coronary Angioplasty Followed by Stent Implantation | 0.5 | 1 | Citations (PDF) |
| 156 | Usefulness of Neopterin, C-reactive Protein, Homocysteine, Pyridoxal-5-phosphate, and Phospholipid Determination in Coronary Artery Disease | 0.5 | 3 | Citations (PDF) |
| 157 | Comparison of early and late results of a Carbofilm-coated stent versus a pure high-grade stainless steel stent (the Carbostent-Trial) | 1.5 | 26 | Citations (PDF) |
| 158 | Heparin-Coated Stent Placement for the Treatment of Stenoses in Small Coronary Arteries of Symptomatic Patients | 13.9 | 86 | Citations (PDF) |
| 159 | Homocysteine, Β Vitamins and Immune Activation in Coronary Heart Disease | 0.5 | 8 | Citations (PDF) |
| 160 | Comparing the sensitivity of pyridoxal-5-phosphate, homocysteine and neopterin in coronary heart disease | 0.5 | 1 | Citations (PDF) |
| 161 | Association between increased serum neopterin and homocysteine concentrations as well as pyridoxal-5-phosphate deficiency in patients with coronary heart disease | 0.5 | 6 | Citations (PDF) |
| 162 | Two-Stent Strategy? Which One to Choose? First Case Example | 0.0 | 0 | Citations (PDF) |
| 163 | Importance of Plaque Modification Before Coronary Artery Stenting | 0.0 | 1 | Citations (PDF) |
| 164 | Association between carotid and coronary atherosclerotic plaque morphology: a virtual histology intravascular ultrasound study | 0.1 | 5 | Citations (PDF) |
| 165 | Ischemia-Guided Coronary Revascularization Following Lower-Extremity Revascularization Improves 5-Year Survival of Patients With Chronic Limb-Threatening Ischemia | 1.3 | 4 | Citations (PDF) |
| 166 | Patterns of Restenosis After Left Main Bifurcation Single- or Dual-Stenting: An EBC MAIN Trial Subanalysis | 3.5 | 5 | Citations (PDF) |
| 167 | From Intracoronary Physiology to Endotype-Based Treatment: Quality of Life Improvement for INOCA Patients | 1.9 | 0 | Citations (PDF) |
| 168 | Comparison of Cryoballoon Ablation Methods in Pulmonary Vein Isolation | 1.6 | 0 | Citations (PDF) |
| 169 | Effects of a Novel Hippophae rhamnoides L. Seed Lipid Extract Formulation Obtained via Supercritical Carbon Dioxide Extraction on Reducing Residual Cardiovascular Risk in High-Risk Patients: A Pilot Study | 1.5 | 1 | Citations (PDF) |
| 170 | Case Report: Severe hypertriglyceridaemia and multivessel coronary artery disease – management and plaque characteristics | 1.7 | 0 | Citations (PDF) |
| 171 | Waiting Time for Pulmonary Vein Isolation: A Single-Center Retrospective Cohort Study of Atrial Fibrillation Progression and Complications | 1.6 | 0 | Citations (PDF) |
| 172 | ESC Membership Global Award 2025: Latvian Society of Cardiology | 7.4 | 0 | Citations (PDF) |
| 173 | 26-A-12787-ACC HOW STABLE ARE CORONARY PLAQUES IN CHRONIC CORONARY SYNDROME PATIENTS? | 6.5 | 0 | Citations (PDF) |
| 174 | Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior Myocardial Infarction: Results From the VESALIUS-CV Trial. | 13.9 | 3 | Citations (PDF) |
| 175 | Real-world use and impact of direct oral anticoagulants among atrial fibrillation patients with cardioembolic stroke. | 1.6 | 0 | Citations (PDF) |
| 176 | Gender-Specific Trends and Determinants of Daily Smoking in Latvia (2009-2019): A Population-Based Cross-Sectional Study. | 1.6 | 0 | Citations (PDF) |
| 177 | Evolocumab and risk of first myocardial infarction: the VESALIUS-CV trial. | 7.4 | 0 | Citations (PDF) |
| 178 | ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey. | 7.4 | 0 | Citations (PDF) |
| 179 | Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event. | 25.2 | 0 | Citations (PDF) |
| 180 | Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial. | 13.9 | 2 | Citations (PDF) |
| 181 | “FROM ZERO TO HERO” – UNFORTUNATE PATH MYOCARDIAL INFARCTION | 1.9 | 0 | Citations (PDF) |
| 182 | YOUNG AGE IS NOT PROTECTIVE: MYOCARDIAL INFARCTION BEFORE THE AGE OF 32 | 1.9 | 0 | Citations (PDF) |
| 183 | Initial Experience with Standalone Thoracoscopic Left Atrial Appendage Occlusion Using AtriClip Pro2: A Single-Center Retrospective Cohort Study in Latvia | 1.6 | 0 | Citations (PDF) |
